ACADIA Pharmaceuticals Inc. vs Credo Technology Group Holding Ltd — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.84 (market cap $5.07B), while Credo Technology Group Holding Ltd trades at $262 (market cap $46.19B). The key difference: Credo Technology Group Holding Ltd is far larger — about 9.1× ACADIA Pharmaceuticals Inc.'s market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Credo Technology Group Holding Ltd nearer its low. Which is the better fit depends on your goals.
| ACAD | CRDO | |
|---|---|---|
Market Cap | $5.07B | $46.19B |
Sector | Health | Technology |
52-Week High | $29.41 | $302.52 |
52-Week Low | $20.06 | $87.81 |
Enterprise Value | $4.19B | $44.77B |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Credo Technology provides high-speed connectivity solutions for AI-driven applications and hyperscale data centers. Its products enable faster, more energy-efficient data transmission for cloud and telecom infrastructure.
Read more on CRDO →